An international commission made the case for focusing on body fat quantity and the illnesses people experience.
There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...
Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties.
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.
In Tuesday's issue of The Lancet Diabetes & Endocrinology, dozens of international medical experts and people with lived ...
A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...
More than a billion people are estimated to be living with obesity worldwide and prescription weight-loss drugs are in high ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback